Balance Sheet
Accounts PayablesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IM Cannabis (IMCC) Other Accumulated Expenses: 2019-2025

Historic Other Accumulated Expenses for IM Cannabis (IMCC) over the last 1 years, with Sep 2025 value amounting to $10.1 million.

  • IM Cannabis' Other Accumulated Expenses rose 469.91% to $10.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.1 million, marking a year-over-year increase of 469.91%. This contributed to the annual value of $3.7 million for FY2024, which is 20.74% down from last year.
  • Per IM Cannabis' latest filing, its Other Accumulated Expenses stood at $10.1 million for Q3 2025, which was up 74.28% from $5.8 million recorded in Q2 2025.
  • IM Cannabis' 5-year Other Accumulated Expenses high stood at $10.1 million for Q3 2025, and its period low was $1.8 million during Q3 2024.
  • Over the past 3 years, IM Cannabis' median Other Accumulated Expenses value was $5.2 million (recorded in 2023), while the average stood at $5.3 million.
  • In the last 5 years, IM Cannabis' Other Accumulated Expenses decreased by 21.62% in 2024 and then surged by 469.91% in 2025.
  • IM Cannabis' Other Accumulated Expenses (Quarterly) stood at $4.6 million in 2023, then declined by 21.62% to $3.6 million in 2024, then soared by 469.91% to $10.1 million in 2025.
  • Its Other Accumulated Expenses stands at $10.1 million for Q3 2025, versus $5.8 million for Q2 2025 and $6.0 million for Q1 2025.